Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
NCT ID: NCT03090828
Last Updated: 2017-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1600 participants
INTERVENTIONAL
2017-09-30
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The total follow up duration is 18 months. Primary endpoint is the cost utility of using app-based therapeutic intervention, secondary endpoints are: compliance with treatment guidelines, app use (professionals and patients), budget impact analysis
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure
NCT02082093
Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.
NCT06257134
Peer Mentorship to Improve Outcomes in Patients on Maintenance Hemodialysis
NCT03595748
Assessment of a Follow-up With Tele-consulting for Patients With Renal Failure Under Peritoneal Dialysis
NCT03019159
Peer Support In Dialysis
NCT05400720
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
treatment as usual will be provided to patients
No interventions assigned to this group
app-based therapeutic education
patients will have access to the app providing information of the disease as well as educational guidelines
app-based therapeutic education
Patients will connect to a platform providing information on end-stage renal disease and to contact health care providers.
enhanced app-based therapeutic education
patients will also have access to a chat room and discussion forum
enhanced app-based therapeutic education
Patients in the enhanced app group will also have access to a social network. (forum, chat room)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
app-based therapeutic education
Patients will connect to a platform providing information on end-stage renal disease and to contact health care providers.
enhanced app-based therapeutic education
Patients in the enhanced app group will also have access to a social network. (forum, chat room)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Leon Berard
OTHER
Université Montpellier
OTHER
Telecom Bretagne
UNKNOWN
Paris School of Economics
UNKNOWN
Ministry of Health, France
OTHER_GOV
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
References
Explore related publications, articles, or registry entries linked to this study.
Pillebout E, Durand-Zaleski I, Farge L, Perrier L, de Chaisemartin C, Dupont JCK, Behaghel L, Rochaix L; Paris School of Economics and AP-HP Hospinnomics, Paris, France. Multicentre, randomised, economic evaluation of a web-based interactive education platform, simple or enhanced, for patients with end-stage renal disease: the PIC-R trial protocol. BMJ Open. 2022 Dec 9;12(12):e062613. doi: 10.1136/bmjopen-2022-062613.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
*P150958
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.